A Randomized, Open-Label Study of Alternative Treatment Combinations of Dideoxycytidine (HIVID; ddC) and Zidovudine (AZT) in Patients With HIV Infection

NCT00002117 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

528

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Zidovudine
DRUG: Zalcitabine

Sponsor

Hoffmann-La Roche